Pfizer CRZ 250 (Xalkori 250 mg)

Generic Name: crizotinib

Pill imprint Pfizer CRZ 250 has been identified as Xalkori 250 mg.

Xalkori is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Xalkori 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Xalkori

Generic Name:

crizotinib

Imprint:

Pfizer CRZ 250

Strength:

250 mg

Color:

Pink

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Multikinase inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Pfizer Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.